JAZZ:NASDAQ
Jazz Pharmaceuticals PLC
218,42 $
arrow_downward
−1,81%(−4,03) 1 p
218,42 $
0,00% (0,00)
bedtimePärast tööaega
Suletud: 9. okt, 16:00:01 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse JAZZ põhistatistika genereerimine…
Ava
221,79 $
Kõrge
227,00 $
Madal
213,20 $
Turu kapit.
14,18 mld
Keskm. maht
935,53 tuh
Maht
1,29 mln
Hinna ja tulu suhe
14,93
52 näd kõrgeim
266,38 $
52 näd madalaim
128,80 $
Aktsiatulu
14,63 $
Beeta
0,37
Käibivad aktsiad
64,92 mln
Töötajate arv
3 tuh
Ava
221,79 $
Kõrge
227,00 $
Madal
213,20 $
Turu kapit.
14,18 mld
Keskm. maht
935,53 tuh
Maht
1,29 mln
Hinna ja tulu suhe
14,93
52 näd kõrgeim
266,38 $
52 näd madalaim
128,80 $
Aktsiatulu
14,63 $
Beeta
0,37
Käibivad aktsiad
64,92 mln
Töötajate arv
3 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Investing.com Nigeria
·
11 tunni eest
Form 144 JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY For: 11 October
TipRanks
·
2 päeva eest
Jazz Pharmaceuticals Plans Commercial Leadership Transition Ahead
ChartMill
·
2 päeva eest
Jazz Pharmaceuticals (NASDAQ:JAZZ): An Undervalued Biopharma Value Stock
AD HOC NEWS
·
3 päeva eest
Truist raises target for Jazz Pharmaceuticals stock to USD 286.00
Profiil
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid. In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness in narcolepsy as well as obstructive sleep apnea. In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America. Wikipedia
Teave üksuse Jazz Pharmaceuticals PLC kohta